AVAvantor, Inc. AVTR · NYSE
$16.30 -0.76% (-$0.13)
- Market cap
- $11.1B
- Enterprise value
- $14.5B
- P/E
- -
- Forward P/E
- 20.2x
- PEG
- -
- P/S
- 1.7x
- P/FCF
- 24.4x
- EV/EBITDA
- 115.7x
- ROIC
- -3.4%
- Gross margin
- 31.8%
- Net margin
- -8.8%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 27.1x
- Beta
- 0.94
- Free float
- 97.3%
About the company
Avantor, Inc. is a global leader in providing integrated, high-quality products, services, and solutions for scientific and advanced technologies. Their portfolio includes a wide range of chemicals, laboratory equipment, materials, and other products serving research laboratories, the pharmaceutical industry, biotechnology, healthcare, and other sectors. Avantor is known for its ability to deliver high-quality products and services and is considered a reliable partner for the scientific community. Shares of Avantor, Inc. could be attractive for investors seeking exponential growth in the field of scientific technologies and advanced materials.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Emmanuel Ligner
Employees
13,500
Headquarters
Radnor
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number